Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2023-05-25 2023-05-08
Drug Identification Number 02457334 02457334
Brand name SANDOZ AMPHETAMINE XR SANDOZ AMPHETAMINE XR
Common or Proper name AMPHETAMINE XR AMPHETAMINE XR
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients MIXED SALTS AMPHETAMINE MIXED SALTS AMPHETAMINE
Strength(s) 25MG 25MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100PRCH 100PRCH
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-08 2023-05-08
Estimated end date 2023-05-19 2023-05-19
Actual end date 2023-05-22
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments